| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/1997 | EP0783308A1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 07/16/1997 | EP0783307A1 Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
| 07/16/1997 | EP0783306A1 Method for improving reproductive efficiency in farm animals |
| 07/16/1997 | EP0783305A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783304A1 Method for treating anxiety |
| 07/16/1997 | EP0783303A1 Use of aromatic halides for treating mammalian cell proliferation |
| 07/16/1997 | EP0783299A1 Compounds and compositions for delivering active agents |
| 07/16/1997 | EP0783283A1 Method and compositions for treating impotence |
| 07/16/1997 | EP0750620A4 Carbapenem compounds, compositions and methods of treatment |
| 07/16/1997 | EP0748166A4 Ready-to-eat cereal product fortified with ferric edta |
| 07/16/1997 | EP0728132B1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/16/1997 | EP0726903B1 Matrix metalloprotease inhibitors |
| 07/16/1997 | EP0725776B1 3-aryl-4-alkyl and 4,5-dialkyl-4h-1,2,4-triazoles useful as memory enhancers |
| 07/16/1997 | EP0691968B1 Acyclic nucleoside analogs and oligonucleotide sequences containing them |
| 07/16/1997 | EP0674645B1 Cephem compounds with antimicrobial activity |
| 07/16/1997 | EP0653936B1 Use of 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
| 07/16/1997 | EP0632812B1 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
| 07/16/1997 | EP0586618B1 The use of nucleic acid analogues in diagnostics and analytical procedures |
| 07/16/1997 | EP0580624B1 Novel cytarabine derivatives, their production and use |
| 07/16/1997 | EP0487602B1 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds |
| 07/16/1997 | CN1154703A Branched oligonucleotides as pathogen-inhibitory agent |
| 07/16/1997 | CN1154702A Oligonucleotides with anti-cytomegalovirus activity |
| 07/16/1997 | CN1154701A 8-fluoro-anthracyclines, process for their prepn. and pharmaceutical compositions contg. them |
| 07/16/1997 | CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
| 07/16/1997 | CN1154698A Benzopyrans and their use as therapeutic agent |
| 07/16/1997 | CN1154696A Deacetoxytaxol derivative |
| 07/16/1997 | CN1154695A Dihydrophenazine derivative, process for producing same, and drug for tubercle bacilli and atypical acid-fast bacilli |
| 07/16/1997 | CN1154693A Benzimidazole derivative having dopaminergic activity |
| 07/16/1997 | CN1154654A Pharmaceutically stable oxaliplatinum prepn. |
| 07/16/1997 | CN1154652A Desquamation compositions |
| 07/16/1997 | CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 07/16/1997 | CN1154359A Method for prepn. and application of germanium amino-acidic |
| 07/16/1997 | CN1154358A Method for prepn. and application of calcium amino-acidic |
| 07/16/1997 | CN1154243A Process for mfg. health-care medicine prepn. containing fish glue |
| 07/16/1997 | CN1154242A Recipe for decreasing side-effect of V-A acidic medicine |
| 07/16/1997 | CN1154241A Compound alkyl camptothecine injection prescription and prepn. process thereof |
| 07/16/1997 | CN1154240A NK-1 receptor antagonists for treatment of cancer |
| 07/16/1997 | CN1154239A Medicine composition for deep tumor by local treatment, and using same in pharmaceutic application |
| 07/15/1997 | US5648585 Process for isomerizing linear olefins to isoolefins |
| 07/15/1997 | US5648563 Retro-alpha-retinol derivative and uses of retro-alpha-retinol |
| 07/15/1997 | US5648523 Fullerene derivatives as free-radical scavengers |
| 07/15/1997 | US5648512 Lipoxin compounds |
| 07/15/1997 | US5648511 Method for making intermediates useful in the synthesis of retroviral protease inhibitors |
| 07/15/1997 | US5648507 Hydration of anhydride of 14-hydroxy-4-androstene-3,16,17 trione |
| 07/15/1997 | US5648498 Cyclization |
| 07/15/1997 | US5648493 Preparation of 7-(3-amino- and 3-amino-methyl-1-pyrrolidinyl)-3-quinolonecarboxylic acids and -naphthyridonecarboxylic acids |
| 07/15/1997 | US5648492 Process for preparing isoquinoline compounds |
| 07/15/1997 | US5648488 Compositions stabilized with red-shifted tris-aryl-s-triazines |
| 07/15/1997 | US5648486 Compounds and methods for the treatment of inflammatory and immune disorders |
| 07/15/1997 | US5648485 β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648474 Antitumor |
| 07/15/1997 | US5648459 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 07/15/1997 | US5648397 Antibiotic, antihistamine, topical |
| 07/15/1997 | US5648396 Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor |
| 07/15/1997 | US5648395 Method of using tartaric acid for treating wrinkles |
| 07/15/1997 | US5648394 Topical composition for inhibiting hair growth |
| 07/15/1997 | US5648391 Method of using galacturonic acid or galacturonolactone for treating wrinkles |
| 07/15/1997 | US5648389 Compositions for the treatment of dermatological disorders and methods for their use |
| 07/15/1997 | US5648388 Method of using methyllactic acid for treating wrinkles |
| 07/15/1997 | US5648387 Carboxyalkylethers, formulations, and treatment of vascular diseases |
| 07/15/1997 | US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 07/15/1997 | US5648385 Retinoid-like compounds |
| 07/15/1997 | US5648383 R-enantiomer of metalaxyl, mancozeb, synergistic |
| 07/15/1997 | US5648382 Angiogenesis inhibitor |
| 07/15/1997 | US5648381 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof |
| 07/15/1997 | US5648380 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 07/15/1997 | US5648379 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents |
| 07/15/1997 | US5648378 2-iminochromene derivatives as inhibitors of protein tyrosine kinase |
| 07/15/1997 | US5648377 Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
| 07/15/1997 | US5648374 Benzospiroalkene compounds |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/15/1997 | US5648372 Antifungal agents, and compositions |
| 07/15/1997 | US5648369 Aminoalkylpyridine compounds which are useful as anitconvulsant drugs, excitatory amino acid inhibitors and NMDA sigma receptor antagonists |
| 07/15/1997 | US5648368 Fibrinogen receptor antagonists |
| 07/15/1997 | US5648367 Antidepresants, obsessive-compulsive disorder |
| 07/15/1997 | US5648365 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 07/15/1997 | US5648364 Heterocyclic peptide compounds as enzyme inhibitors |
| 07/15/1997 | US5648363 N-[(4-heteroaryl-1-piperidinyl)alkyl]-1H-benz[de]isoquinoline-1,3(2H) - diones and related compounds and their therapeutic utility |
| 07/15/1997 | US5648362 Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses |
| 07/15/1997 | US5648361 Rapamycin derivatives |
| 07/15/1997 | US5648359 Tumor necrosis factor production inhibitors |
| 07/15/1997 | US5648358 Caffeine and pyrrolidine or piperidine ether antihistamine |
| 07/15/1997 | US5648357 Enatiomerically pure hydroxylated xanthine compounds |
| 07/15/1997 | US5648356 Treatment of serotonin related disorders |
| 07/15/1997 | US5648355 Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| 07/15/1997 | US5648351 Use of macrolides for the treatment of cerebral ischemia |
| 07/15/1997 | US5648350 Prostate |
| 07/15/1997 | US5648347 Arylmorpholine, preparation and use |
| 07/15/1997 | US5648346 Antimicrobial carbacephem-quinolones |
| 07/15/1997 | US5648345 Treatment for toxoplasmosis with a composition comprising a macrolide antibiotic and a spiropiperidyl derivative of rifamycin S |
| 07/15/1997 | US5648344 Methods of treating inflammation using selection binding compounds |
| 07/15/1997 | US5648343 Method for treating LPS-mediated disorders |
| 07/15/1997 | US5648341 Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution |
| 07/15/1997 | US5648335 Prevention and treatment of peripheral neuropathy |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648239 Human camp-dependent protein kinase inhibitor homolog |
| 07/15/1997 | US5648238 Human protein kinase C inhibitor homolog |
| 07/15/1997 | US5648100 Acrylamide polymers |
| 07/15/1997 | US5648098 Dextrose, albumin, microbubbles |